In metabolic diseases, the expression of NLRP3 inflammasome will increase, and now more and more evidence suggests that NLRP3 inflammasome plays an important role in many noninfectious inflammatory diseases, such as gout, atherosclerosis, and diabetes [38]. Here, NLRP3 is linked to atherosclerosis.